Process for preparing aqueous dispersions of biocide-free organic opaque pigment particles

By preparing aqueous dispersions containing core/shell polymer particles in the coating industry, combining redox coupling agents and chelating agents, the problem of microbial contamination in the coating industry is solved, and a safe and sustainable anticorrosion effect is achieved. Avoid the problems caused by high pH.

CN118922461APending Publication Date: 2024-11-08ROHM & HAAS CO
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202380028871.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-03-29
Filing Date
2023-03-23
Publication Date
2024-11-08

Smart Images

  • Figure BDA0005051206820000041
    Figure BDA0005051206820000041
Patent Text Reader

Abstract

The present invention relates to a process for preparing an aqueous dispersion of core-shell opaque organic pigment particles. The method comprises, after the post-swelling step, a step of introducing an excess amount of t-C4-C10-alkyl hydrogen peroxide or post-adding hydrogen peroxide in the presence of a chelating agent that is not complexed with a multivalent metal cation.
Need to check novelty before this filing date? Find Prior Art

Description

Background Art

[0001] The present invention relates to a process for preparing an aqueous dispersion of organic opaque pigment particles that exhibit resistance to microbial growth in the absence of a biocide.

[0002] Aqueous intermediates used in the coating industry are preserved with biocides to inhibit the formation and growth of biological organisms (such as bacteria, yeasts and molds) while in storage. Inhibition of these organisms prevents product degradation and spoilage, as well as the outgassing of volatile products and subsequent pressure buildup in closed containers. Preservation is therefore necessary for health, safety and performance reasons.

[0003] Can preservatives such as isothiazolinones are facing intense regulatory scrutiny for their real or perceived adverse effects on health, safety and the environment; in fact, a total ban on these biocides appears imminent in many parts of the world. To the extent that the development of new biocides is not possible due to cost reasons and the widespread perception (whether justified or not) of the inherent dangers of these biocides, there is a need to replace biocides with alternative non-biocidal preservatives that are safer and more sustainable.

[0004] In EP 3 456 787 B1, can be found for the preservation of coatings to prevent the recent example of non-biocidal methods of microbial contamination, the document discloses pH adjustment to the aqueous coating formulations in the range of 10 to 12.5. Although effective on the surface, these formulations of very high pH have produced other safety and sanitation issues, making this method impractical. Other non-traditional methods such as adding silver or zinc ions may adversely affect the characteristics of coatings, and also face regulatory review. Due to these reasons, it is necessary to be used to preserve other safer and more sustainable methods of coatings and coating additives. Summary of the invention

[0005] The present invention addresses the need in the art by providing a method for preparing an aqueous dispersion of opaque organic pigment particles, the method comprising the steps of:

[0006] a) contacting the aqueous dispersion of core polymer particles with a first monomer under emulsion polymerization conditions in the presence of a free radical initiator to form an aqueous dispersion of core / first stage polymer particles; and then

[0007] b) contacting the dispersion of core / first stage polymer particles with a free radical chaser; and then

[0008] c) contacting the dispersion of core / first stage polymer particles from step b) with: i)

[0009] 8 to 20 wt % of the swelling monomer, based on the weight of the core / first stage polymer particles and swelling monomer; and ii) a polymerization inhibitor that inhibits polymerization of the swelling monomer;

[0010] Then

[0011] d) contacting the dispersion from step c) with a neutralizing swelling agent to neutralize the core and induce swelling of the core with water;

[0012] e) initiating polymerization of the swelling monomer with a redox coupling agent to form an aqueous dispersion of core / shell polymer particles having less than 1000 ppm of unreacted swelling monomer; and optionally

[0013] f) adding hydrogen peroxide and a chelating agent that is not complexed with a multivalent metal cation;

[0014] wherein the core polymer particles comprise from 20% to 60% by weight of structural units of salts of carboxylic acid monomers and from 40% to 80% by weight of structural units of nonionic monoethylenically unsaturated monomers;

[0015] The T of the first monomer and the swelling monomer g In the range of 60°C to 120°C;

[0016] The weight ratio of the core polymer particles to the sum of the first monomer and the swelling monomer is from 1:9 to

[0017] In the range of 1:20;

[0018] The redox coupling agent comprises t-C4-C 10 -alkyl hydroperoxide and a reducing agent; provided that when step f) is not performed, the t-C4-C 10 -alkyl hydroperoxide to the reducing agent in a molar ratio of 5: 1 to 50: 1; and when performing step f), t-C4-C 10 The molar ratio of the alkyl hydroperoxide to the reducing agent is in the range of 2:1 to 3:1, and the amount of hydrogen peroxide added is in the range of 0.1 wt% to 1 wt% based on the weight of the composition, and the amount of the chelating agent not complexed with the polyvalent metal cation is in the range of 50 ppm to 1000 ppm.

[0019] The present invention addresses the need in the art by providing a method for preparing an opaque polymer that is resistant to microbial contamination without the use of biocides. DETAILED DESCRIPTION

[0020] The present invention is a method for preparing an aqueous dispersion of opacifying agent organic pigment particles, the method comprising the following steps:

[0021] a) contacting the aqueous dispersion of core polymer particles with a first monomer under emulsion polymerization conditions in the presence of a free radical initiator to form an aqueous dispersion of core / first stage polymer particles; and then

[0022] b) contacting the dispersion of core / first stage polymer particles with a free radical chaser; and then

[0023] c) contacting the dispersion of the core / first stage polymer particles with: i) 8% to 20% by weight of the swelling monomer, based on the weight of the core / first stage polymer particles and swelling monomer; and ii) a polymerization inhibitor that inhibits polymerization of the swelling monomer; and then

[0024] d) contacting the dispersion from step c) with a neutralizing swelling agent to neutralize the core and induce swelling of the core with water;

[0025] e) initiating polymerization of the swelling monomer with a redox coupling agent to form an aqueous dispersion of core / shell polymer particles having less than 1000 ppm of unreacted swelling monomer; and optionally

[0026] f) adding hydrogen peroxide and a chelating agent that is not complexed with a multivalent metal cation;

[0027] wherein the core polymer particles comprise from 20% to 60% by weight of structural units of salts of carboxylic acid monomers and from 40% to 80% by weight of structural units of nonionic monoethylenically unsaturated monomers;

[0028] The T of the first monomer and the swelling monomer g In the range of 60°C to 120°C;

[0029] The weight ratio of the core polymer particles to the sum of the first monomer and the swelling monomer is in the range of 1:9 to 1:20;

[0030] The redox coupling agent comprises t-C4-C 10 -alkyl hydroperoxide and a reducing agent; provided that when step f) is not performed, the t-C4-C 10 -alkyl hydroperoxide to the reducing agent in a molar ratio of 5: 1 to 50: 1; and when performing step f), t-C4-C 10 The molar ratio of the alkyl hydroperoxide to the reducing agent is in the range of 2:1 to 3:1, and the amount of hydrogen peroxide added is in the range of 0.1 wt% to 1 wt% based on the weight of the composition, and the amount of the chelating agent not complexed with the polyvalent metal cation is in the range of 50 ppm to 1000 ppm.

[0031] The core polymer particles comprise from 20 wt %, preferably from 25 wt %, more preferably from 30 wt %, and most preferably from 32 wt % to 60 wt %, preferably to 50 wt %, more preferably to 40 wt %, and most preferably to 36 wt % of structural units of salts of carboxylic acid monomers, based on the weight of the structural units of the monomers in the core.

[0032] As used herein, the term "structural unit" refers to the residue of the monomer after polymerization. For example, the structural unit of methacrylate, wherein M + is a counterion, preferably a lithium, sodium or potassium counterion, as shown:

[0033]

[0034] Examples of suitable carboxylic acid monomers include acrylic acid, methacrylic acid, itaconic acid, and maleic acid.

[0035] The core polymer particles also contain 40 wt %, preferably 50 wt %, more preferably 55 wt %, more preferably 60 wt %, and most preferably 64 wt % to 80 wt %, preferably to 75 wt %, more preferably to 70 wt %, and most preferably to 68 wt % of structural units of nonionic monoethylenically unsaturated monomers based on the weight of the structural units of the monomers in the core. Examples of nonionic monoethylenically unsaturated monomers include one or more acrylates and / or methacrylates, such as methyl acrylate, ethyl acrylate, n-butyl acrylate, tert-butyl acrylate, 2-ethylhexyl acrylate, methyl methacrylate, n-butyl methacrylate, tert-butyl methacrylate, isobutyl methacrylate, isobornyl methacrylate, lauryl methacrylate, and cyclohexyl methacrylate; and one or more monoethylenically unsaturated aromatic compounds, such as styrene, α-methylstyrene, and 4-tert-butylstyrene. A preferred nonionic monoethylenically unsaturated monomer is methyl methacrylate.

[0036] In the first step of the process of the present invention, an aqueous dispersion of core polymer particles is contacted with a first monomer having a homopolymer having a calculated T g In the range of 60°C, or 80°C, or 90°C, or 95°C to 115°C or to 110°C. As used herein, "first monomer" refers to one or more first monomers. The homopolymer T reported in Polymer Handbook, 4th edition (1999, John Wiley & Sons, Inc.) is used. g Data, T is calculated by Fox equation g .

[0037] Preferably, the first monomer comprises methyl methacrylate, styrene, α-methylstyrene, isobornyl methacrylate, lauryl methacrylate or cyclohexyl methacrylate. In one aspect, the first monomer comprises at least 80 wt%, at least 90 wt% or at least 95 wt% of styrene structural units. In another embodiment, the first monomer comprises 89 wt% to 93 wt% of styrene structural units and 7 wt% to 11 wt% of any one or all of methyl methacrylate (4 wt% to 5 wt%), cyclohexyl methacrylate (0.9 wt% to 2 wt%), methacrylic acid (2 wt% to 3 wt%) and the multiethylenically unsaturated monomer allyl methacrylate (ALMA, 0.1 wt% to 0.5 wt%).

[0038] The first monomer may further comprise other polyethylenically unsaturated monomers, such as divinylbenzene (DVB), trimethylolpropane trimethacrylate (TMPTMA) or trimethylolpropane triacrylate (TMPTA). The first monomer may be added in multiple stages, wherein the first stage forms the so-called tie layer.

[0039] In the second step, a free radical chaser is added to the reaction mixture to inhibit polymerization of the subsequently added swelling monomer. Examples of suitable free radical chasers include oxidizable metal salts (such as FeSO4) that become water soluble at high pH by forming a water soluble complex with a chelating agent, which is used as a limiting agent in this step. Examples of suitable chelating agents include diaminocarboxylates, such as the tetrasodium salt of ethylenediaminetetraacetic acid (tetrasodium EDTA), which can be used as a VERSENE TM Chelating agents are commercially available as DeQuest® (trademark of The Dow Chemical Company or its affiliates), and hydroxyethylidene diphosphonates, such as tetrasodium salt of 1-hydroxyethylidene-1,1-diphosphonic acid, are commercially available as DeQuest® 2016 chelating agent.

[0040] After adding the free radical chaser, the T gA swelling monomer in the range of 60°C, or 80°C, or 90°C to 120°C or to 110°C and a polymerization inhibitor are added to the reaction mixture. In one aspect, the swelling monomer comprises at least 80% by weight or at least, or at least 90% by weight or at least 95% by weight of styrene. In another aspect, the swelling monomer comprises 89% to 93% by weight of styrene and 7% to 11% by weight of any one or all of methyl methacrylate (4% to 5% by weight), cyclohexyl methacrylate (0.9% to 2% by weight), methacrylic acid (2% to 3% by weight) and a polyethylenically unsaturated monomer allyl methacrylate (ALMA, 0.1% to 0.5% by weight). Examples of polymerization inhibitors include 4-hydroxy-2,2,6,6, tetramethylpiperidinyloxy, free radical (4-hydroxy-TEMPO), hydroquinone, p-methoxyhydroquinone, tert-butyl p-hydroquinone and 4-tert-butylcatechol. The concentration of the added swelling monomer is in the range of 8 wt% to 20 wt% based on the core / first stage polymer particles and swelling monomer.

[0041] After the addition of the swelling monomer and the polymerization inhibitor is complete, a swelling agent is added to the aqueous dispersion of the multi-stage polymer particles to penetrate the shell or the middle layer and induce swelling of the core with water. The swelling agent is a base such as ammonium hydroxide, LiOH, NaOH and KOH. Next, in a key step of one aspect of the method of the present invention, C4-C 10 -t-Alkyl hydroperoxide, preferably C4-C 10 -t-alkyl hydroperoxide, more preferably tert-butyl hydroperoxide or tert-amyl hydroperoxide and a reducing agent such as isoascorbic acid in a C4-C4 ratio in the range of 5:1, or 7.5:1, or 12:1 to 50:1, or to 30:1 or to 20:1. 10 -t-alkyl hydroperoxide to reducing agent molar ratio is added to the aqueous dispersion. This ratio is significantly higher than previously reported ratios in the range of 2.0:1 to 3.0:1, and is therefore significantly higher than the ratio required to chase residual monomer. Clearly, there is no obvious reason to add more oxidant than the amount taught to be sufficient to chase residual monomer.

[0042] Advantageously, the t-alkyl hydroperoxide is added all at once, followed by gradual addition of the reducing agent. It may also be advantageous to add a portion of the t-C4-C 10 -alkyl hydroperoxide, and then add the remaining portion of the t-C4-C 10-Alkyl hydroperoxide. For example, 1235 ppm of tert-butyl hydroperoxide may be added to the dispersion at once, followed by gradual addition of 305 ppm of isoascorbic acid; alternatively, 412 ppm of tert-butyl hydroperoxide may be added to the dispersion at once, followed by gradual addition of 305 ppm of isoascorbic acid, followed by 823 ppm of tert-butyl hydroperoxide.

[0043] In another aspect, the redox coupling agent is added at a ratio in the range of 2.0:1 to 3.0:1, and hydrogen peroxide and the unconjugated polyvalent metal ion (such as Fe) are added later. +2 ) complexed with a chelating agent. In this regard, the amount of hydrogen peroxide added is in the range of 0.1 wt % to 1 wt % based on the weight of the composition, and the amount of chelating agent not complexed with the multivalent metal cation is in the range of 50 ppm to 1000 ppm based on the weight of the composition.

[0044] The solids content of the multi-stage polymer particles is preferably in the range of 10 wt % to 40 wt %, based on the weight of the composition.

[0045] In one aspect, the process of the present invention results in the formation of multistage polymer particles having a z-average particle size preferably in the range of 950 nm to 2000 nm; in another aspect, the multistage polymer particles have a z-average particle size preferably in the range of 300 nm, more preferably 350 nm, and most preferably 375 nm to preferably 600 nm, more preferably to 500 nm, and most preferably to 425 nm. As used herein, z-average particle size refers to the particle size determined by dynamic light scattering, for example by a BI-90 Plus particle size analyzer (Brookhaven). The multistage polymer particles preferably comprise 10% to 35% by weight of the composition.

[0046] In addition to achieving the goal of reinitiating polymerization and chemically converting the amount of unreacted monomer from a level typically in the range of 8% to 20% by weight based on the weight of the multi-stage polymer particles and unreacted monomer to a level below 1000 ppm, preferably below 500 ppm, the presence of a significant excess of an oxidizing agent of the type described herein produces an opaque polymer composition that resists microbial attack. In contrast, when conventional amounts of tert-butyl hydroperoxide described in the prior art are used (in the range of 2.0:1 to 3.0:1 molar ratios relative to isoascorbic acid without post-addition of hydrogen peroxide and chelating agents), the resulting concentration of tert-butyl hydroperoxide (about 350 ppm) is insufficient to act as a preservative when the final concentration of unreacted monomer is less than 1000 ppm.

[0047] It has been found that adding t-C4-C4 in a large excess over that which is conventionally added to chemically convert the monomers into part of the shell of the multi-stage polymer particle is effective. 10 -Alkyl hydroperoxides preserve the substantially monomer-free dispersion of the multi-stage polymer particles to prevent microbial attack. More particularly, the addition of tert-butyl hydroperoxide or tert-amyl hydroperoxide in the above mole:mole ratio after the swelling step results in excellent corrosion protection properties without the need for biocides.

[0048] Provides corrosion protection (where H2O2 is the oxidant) or improved corrosion protection (in t-C4-C 10 The amount of additional chelating agent (in some cases where t-C4-C4-alkyl hydroperoxide is the oxidizing agent) is higher than that required to complex with any free (non-complexed) metal cations. The disclosed method describes the use of a stoichiometric excess of the metal salt, leaving no residual chelating agent that is not complexed with the metal salt. It has been found that when hydrogen peroxide is used, the presence of a sufficient amount of additional chelating agent is necessary to achieve an anticorrosive effect, and when t-C4-C4-alkyl hydroperoxide is used, the amount of additional chelating agent is greater than that required to complex with any free (non-complexed) metal cations. 10 -alkyl hydroperoxides are sometimes useful to improve corrosion protection.

[0049] When used, non-complexing chelating agents are typically added at a concentration ranging from 100 ppm to 2000 ppm based on the weight of the composition.

[0050] It has been found that preservation of aqueous dispersions of opaque polymers can be achieved at relatively low pH, typically 7.5 or 8.0 to 9.5 or to 9.0; it has also been found that preservation comparable to that achieved with biocides can be achieved at relatively low pH without the need for any biocides. Thus, in another aspect, the method of the invention excludes the step of adding any biocide.

[0051] Example

[0052] NMR spectroscopy determination of t-AHP or t-BHP in serum phase

[0053] Into about 10mL polycarbonate tube, 3.0mL latex sample, 3.0mL Milli-Q water are loaded, and centrifuged at 100,000rpm for 15 minutes. The obtained clear supernatant is carefully decanted and transferred to 5-mm NMR tube. The flame-sealed capillary filled with external standard (5.000wt% d4-trimethylsilyl sodium propionate in D2O) is added to the NMR tube. Carefully note the correct alignment of the external standard in the NMR tube. Use the BrukerAVANCE III 600 spectrometer equipped with a 5-mm BroadBand CryoProbe to obtain NMR spectrum. Each sample is tuned and shimmed individually, but the pulse width and receiver gain remain constant for the sample series. The concentration of free tert-amyl hydroperoxide or tert-butyl hydroperoxide was measured by using a zg pulse sequence with the following parameters: acquisition time (aq) = 2.5 seconds, recycle delay (d1) = 30 seconds, number of transients (ns) = 1024, receiver gain (rg) = 32, and pulse width (p1) = 11 milliseconds. All other parameters (time domain size, scan width, dwell time, prescan delay, and carrier frequency) were kept at default values. The concentration of free hydrogen peroxide was calculated by comparing the peak resonating around 1.2 ppm with the integral of the peak of an external standard at 0.0 ppm. The spectra were referenced to an external standard at 0.0 ppm on a trimethylsilyl chemical shift scale.

[0054] Preparation of samples for antimicrobial resistance

[0055] The samples were tested for antimicrobial properties "as is" (not heat aged) and after being subjected to 50°C for four weeks (heat aged). A 10-g aliquot was taken from each sample and heated to 10 6 -10 7The samples were inoculated three times with a pool of standard bacteria, yeasts and molds (obtained from the American Type Culture Collection (ATCC) for common contaminants in coatings) with 7-day intervals. After inoculation, the samples were stored in 25°C incubators. The microbial contamination of the test samples was monitored by agar plate inoculation using the standard streak plate method. The samples were inoculated on tryptic soy agar (TSA) and potato dextrose agar (PDA) plates on the 1st and 7th days after each microbial attack. All agar plates were checked daily until the 7th day after inoculation to determine the number of microorganisms that survived in the test samples. Between inspections, agar plates were stored in an incubator, at 30°C for TSA plates, and at 25°C for PDA plates. The degree of microbial contamination was determined by counting colonies, where the rating score was determined according to the number of microbial colonies observed on agar plates. The reported results are from the 7th day readings, and are summarized for both "as is" and heat aging samples. Results are described by a score for each type of microorganism: B = bacteria, Y = yeast, and M = mold. For example, 3B describes a plate with a score of 3 for bacteria, or Tr Y(1) describes a plate with trace yeast (1 colony on the plate). Table 1 illustrates the rating system used to estimate the level of microbial contamination on the planned plate. Colony refers to the number of colonies on the plate.

[0056] Table 1 - Rating system for estimating microbial contamination

[0057] Colony Rating score pollute result none 0 none qualified 1-9 Tr Trace qualified 10 to 99 1 Very slight Failure 100 to about 1000 2 slight Failure About 1000 to 10,000 3 Moderate Failure >10,000 4 Severe Failure

[0058] In Table 1, "pass" means less than ten colonies were detected on the plate on a specific day after inoculation (Day 1 (D1) or Day 7 (D7)). "Fail" means ten or more different colonies were detected on the plate on a specific day after inoculation.

[0059] Comparative Example - Preparation of Aqueous Dispersion of Multi-stage Polymer Particles

[0060] In the following description, core #1 refers to an aqueous dispersion of polymer particles (66 MMA / 34 MAA, 32.0% solids, z-average particle size of 135 nm) prepared essentially as described in US 6,020,435.

[0061] A 5-L four-necked round bottom flask was equipped with a paddle stirrer, a thermometer, a N2 inlet, and a reflux condenser. DI water (730.64 g) and acetic acid (0.28 g in 1.64 g water) were added to the vessel and the contents were heated to 89 ° C under N2. Sodium persulfate (NaPS, 3.39 g in 24.55 g water) was immediately added to the vessel, followed by core # 1 (218.53 g). Then within 60 minutes, a monomer emulsion 1 (ME 1) prepared by mixing DI water (69.55 g), Polystep A-16-22 emulsifier (5.5 g), styrene (69.95 g), methacrylic acid (8.43 g), and methyl methacrylate (61.53 g) was added to the vessel. During the ME 1 feed, the temperature of the reaction mixture was kept constant at 78 ° C, after which a DI water rinse (32.73 g) was added. After the ME 1 feed was completed, monomer emulsion 2 (ME 2) prepared by mixing DI water (217.64 g), Polystep A-16-22 emulsifier (11.09 g), styrene (657 g), linseed oil fatty acid (4.17 g), allyl methacrylate (2.13 g) and methacrylic acid (12.6 g) was fed into the vessel over 60 minutes. The temperature of the reaction mixture was raised to 84° C. after 15 minutes and to 92° C. after 25 minutes. Simultaneously with the start of the ME 2 feed, a NaPS solution (0.93 g in 62.18 g water) was co-fed into the vessel over 65 minutes. After the ME 2 feed was completed, a DI water rinse (32.73 g) was added to the vessel followed by ferrous sulfate heptahydrate (16.36 g of 0.1 wt. % FeSO4·7H2O) and VERSENE TM An aqueous mixture of chelating agent (1.64 g of 1 wt.% EDTA tetrasodium salt) was added to the vessel followed by hot DI water (>60°C, 182.45 g).The contents of the reaction mixture were maintained at 90-92°C for 15 minutes.

[0062] ME 3 prepared by mixing DI water (57.27 g), Polystep A-16-22 emulsifier (2.05 g), styrene (167.73 g) and 4-hydroxy TEMPO (1.88 g) was fed into the container over 5 minutes, and the temperature of the reaction mixture was reduced to 85° C. Immediately after the ME 3 feed addition was completed, NaOH (29.45 g, 50 wt.% aqueous solution) mixed with hot DI water (572.73 g) was added to the container over 10 minutes. When the NaOH addition was complete, the batch was held for 5 minutes. After the holding was completed, a post-polymerization solution of t-BHP (2.12 g, 70 wt.% aqueous solution) in DI water (24.55 g) was added to the container, and a separate solution of isoascorbic acid (IAA, 1.1 g) in water (65.45 g) was fed into the container over 25 minutes. After the addition of the second co-feed was complete, DI water (94.11 g) was added to the vessel and the dispersion was cooled to room temperature and filtered to remove any coagulum. The solids content of the filtered dispersion was 31.0% and the pH was measured to be 8.3. NMR spectroscopy analysis of the serum phase of the sample revealed a t-BHP concentration of <300 ppm.

[0063] Comparative Example 2 - Preparation of an aqueous dispersion of multi-stage polymer particles

[0064] An aqueous dispersion of multistage polymer particles was prepared essentially as described in Example 1 of US 6,384,104, wherein the pH was adjusted to 8. Proton NMR spectroscopy analysis of the serum phase of the sample revealed a t-BHP concentration of <350 ppm.

[0065] Example 1

[0066] The process was carried out essentially as described in the Comparative Example, except that upon completion of the hold after the NaOH addition, a post-polymerization solution of t-AHP (6.05 g, 85 wt.% aqueous solution) in DI water (24.55 g) was added to the vessel. The solids content of the filtered dispersion was 31.0%, and the pH was measured to be 8.3. Proton NMR spectroscopy analysis of the serum phase of the sample revealed a t-AHP concentration of 740 ppm.

[0067] Example 2

[0068] The process was carried out essentially as described in the Comparative Example, except that upon completion of the post-NaOH addition hold, a post-polymerization solution of t-BHP (6.36 g, 70 wt.% aqueous solution) in DI water (24.55 g) was added to the vessel. The filtered dispersion had a solids content of 30.3% and a pH of 8.3 was measured. Proton NMR spectroscopy analysis of the serum phase of the sample revealed a t-BHP concentration of 920 ppm.

[0069] Example 3

[0070] The process was carried out essentially as described in the Comparative Example, except that upon completion of the post-NaOH addition hold, a post-polymerization solution of t-AHP (10.05 g, 85 wt.% aqueous solution) in DI water (24.55 g) was added to the vessel. The filtered dispersion had a solids content of 29.7% and a pH of 8.3 was measured. Proton NMR spectroscopy analysis of the serum phase of the sample revealed a t-AHP concentration of 1050 ppm.

[0071] Example 4

[0072] The method was carried out essentially as described in Example 2, except that Dequest 2016 chelating agent solution (7.2 g, 5 wt.% aqueous solution) was added and mixed for 5 minutes before filtration and after the dispersion was cooled to <50°C. The solids content of the filtered dispersion was 30.3%, and the pH was measured to be 8.3. Proton NMR spectroscopy analysis of the serum phase of the sample revealed a t-BHP concentration of 915 ppm.

[0073] Example 5

[0074] The method is carried out substantially as described in the comparative example, except that before filtering and after the dispersion is cooled to <50°C, a solution of Dequest 2016 chelating agent (1.8 g, 5 wt.% aqueous solution) in DI water (16.36 g) is added to the container within 5 minutes. Then a solution of hydrogen peroxide (48.48 g, 30 wt% aqueous solution) in DI water (16.36 g) is added to the container within 15 minutes. The dispersion is then filtered to remove any coagulum. The solid content of the filtered dispersion is 29.5%, and the pH is measured to be 8.5. Table 1 shows the results of the heat aging excitation test of the embodiment. The subscript "o" refers to the excitation test leaving the mill ("as is"), and the subscript "Δ" refers to the heat aging excitation test for seven days.

[0075] Table 1 - Provocation test results

[0076] <![CDATA[C1 o ]]> <![CDATA[C2 o ]]> <![CDATA[C3 o ]]> <![CDATA[C1 Δ ]]> <![CDATA[C2 Δ ]]> <![CDATA[C3 Δ ]]> Comparison 1 Failure Failure Failure Failure Failure Failure Comparison 2 Failure Failure Failure Failure Failure Failure Example 1 qualified qualified qualified qualified qualified Failure Example 2 qualified qualified qualified qualified qualified Failure Example 3 qualified qualified qualified qualified qualified qualified Example 4 qualified qualified qualified qualified qualified qualified Example 5 qualified qualified qualified qualified qualified qualified

[0077] The data show that t-BHP and t-AHP are effective as preservatives for aqueous dispersions of opaque polymers. Chelating agents were used to achieve efficacy for the third heat aging challenge test (Example 3) at a concentration three times higher than that used under normal emulsion polymerization conditions (Comparative Example 1). Chelating agents were not required when the concentration of t-alkyl hydroperoxide was five times that of Comparative Example 1 (Example 4). In the presence of chelating agents, H2O2 was effective in all heat aging challenge tests.

Claims

1. A method for preparing an aqueous dispersion of multi-stage polymer particles, the method comprising the following steps: a) contacting an aqueous dispersion of core polymer particles with a first monomer under emulsion polymerization conditions in the presence of a free radical initiator to form an aqueous dispersion of core / first stage polymer particles; Then b) contacting the dispersion of core / first stage polymer particles with a free radical chaser; Then c) contacting the dispersion of the core / first stage polymer particles from step b) with: i) 8% to 20% by weight of the swelling monomer, based on the weight of the core / first stage polymer particles and swelling monomer; and ii) a polymerization inhibitor that inhibits polymerization of the swelling monomer; and then d) contacting the dispersion from step c) with a neutralizing swelling agent to neutralize the core and induce swelling of the core with water; e) initiating polymerization of the swelling monomer with a redox coupling agent to form an aqueous dispersion of core / shell polymer particles having less than 1000 ppm of unreacted swelling monomer; and optional f) adding hydrogen peroxide and a chelating agent that is not complexed with a multivalent metal cation; wherein the core polymer particles comprise from 20% to 60% by weight structural units of salts of carboxylic acid monomers and from 40% to 80% by weight structural units of nonionic monoethylenically unsaturated monomers; The T of the first monomer and the swelling monomer g In the range of 60°C to 120°C; a weight ratio of core polymer particles to the sum of the first monomer and the swelling monomer in a range of 1:9 to 1:20; The redox coupling agent comprises t-C4-C 10 -alkyl hydroperoxide and a reducing agent; provided that when step f) is not performed, the t-C4-C 10 -alkyl hydroperoxide to the reducing agent in a molar ratio of 5: 1 to 50: 1; and when performing step f), t-C4-C 10 - The molar ratio of alkyl hydroperoxide to the reducing agent is in the range of 2:1 to 3:1, and the amount of hydrogen peroxide added is in the range of 0.1 wt% to 1 wt% based on the weight of the composition, and the amount of the chelating agent not complexed with the multivalent metal cation added is in the range of 50 ppm to 1000 ppm.

2. The method according to claim 1, wherein the t-C4-C 10 The molar ratio of the alkyl hydroperoxide to the reducing agent is in the range of 5:1 to 50:

1.

3. The method according to claim 2, wherein the t-C4-C 10 The molar ratio of the t-C4-C4-alkyl hydroperoxide to the reducing agent is in the range of 7.5:1 to 30:1, wherein the t-C4-C4-alkyl hydroperoxide is 10 The -alkyl hydroperoxide is tert-butyl hydroperoxide or tert-amyl hydroperoxide.

4. The method according to claim 3, wherein the t-C4-C 10 -alkyl hydroperoxide is tert-butyl hydroperoxide, wherein the swelling monomer comprises at least 80% by weight of styrene, the neutralizing swelling agent is ammonium hydroxide, LiOH, NaOH or KOH, and the t-C4-C 10 - The molar ratio of the alkyl hydroperoxide to the reducing agent is in the range of 12:1 to 20:

1.

5. The method according to claim 3, wherein the t-C4-C 10 -alkyl hydroperoxide is tert-amyl hydroperoxide, wherein the swelling monomer comprises at least 80 wt. % styrene, the neutralizing swelling agent is ammonium hydroxide, LiOH, NaOH or KOH, and the t-C4-C 10 - The molar ratio of the alkyl hydroperoxide to the reducing agent is in the range of 12:1 to 20:

1.

6. The method according to claim 1, wherein t-C4-C 10- the molar ratio of alkyl hydroperoxide to the reducing agent is in the range of 2:1 to 3:1, and hydrogen peroxide is added in step f) at a concentration in the range of 0.1 wt.-% to 1 wt.-%, based on the weight of the composition, and the chelating agent not complexed with the metal cation is added in step f) at a concentration in the range of 50 ppm to 1000 ppm.

7. The method according to any one of claims 1 to 6, wherein the reducing agent is isoascorbic acid, the chelating agent is the sodium salt of ethylenediaminetetraacetic acid or the tetrasodium salt of 1-hydroxyethylidene-1,1-diphosphonic acid, and the pH of the final dispersion is in the range of 7.5 to 9.

5.

8. The method according to any one of claims 2 to 5, further comprising the step of adding a chelating agent that is not complexed with the polyvalent metal cation after step e), wherein the reducing agent is isoascorbic acid.

9. The method according to any one of claims 2 to 5, wherein a portion of the t-C4-C 10 -alkyl hydroperoxide, and after the addition of the reducing agent is completed, the remaining portion of the t-C4-C 10 -Alkyl hydroperoxides.

10. The method of claim 8, wherein the chelating agent is a sodium salt of ethylenediaminetetraacetic acid or a tetrasodium salt of 1-hydroxyethylidene-1,1-diphosphonic acid.

Citation Information

Patent Citations

  • Water-borne coating formulation

    EP3456787B1

  • Process for preparing polymer core shell type emulsions and polymers formed therefrom

    US6020435A

  • Method for preparing ultraviolet radiation-absorbing compositions

    US6384104B1